PML‐mediated nuclear loosening permits immunomodulation of mesenchymal stem/stromal cells under inflammatory conditions.
- Published in:
- Cell Proliferation, 2024, v. 57, n. 4, p. 1, doi. 10.1111/cpr.13566
- By:
- Publication type:
- Article
Works matching AU Gong, Pixia
Results: 5
1
2
Glucocorticoid activates STAT3 and NF-κB synergistically with inflammatory cytokines to enhance the anti-inflammatory factor TSG6 expression in mesenchymal stem/stromal cells.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41419-024-06430-1
- By:
- Publication type:
- Article
3
Mesenchymal stem/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05445-w
- By:
- Publication type:
- Article
4
Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01264-2
- By:
- Publication type:
- Article
5
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells.
- Published in:
- Biology Direct, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13062-023-00415-4
- By:
- Publication type:
- Article